CAI
Price
$17.59
Change
+$0.28 (+1.62%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
4.97B
56 days until earnings call
Intraday BUY SELL Signals
VTGN
Price
$0.62
Change
-$0.02 (-3.12%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
25.94M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CAI vs VTGN

CAI vs VTGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CAI vs. VTGN commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAI is a StrongBuy and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (CAI: $17.31 vs. VTGN: $0.63)
Brand notoriety: CAI and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAI: 110% vs. VTGN: 116%
Market capitalization -- CAI: $4.89B vs. VTGN: $25.94M
CAI [@Biotechnology] is valued at $4.89B. VTGN’s [@Biotechnology] market capitalization is $25.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAI’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • CAI’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CAI and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAI’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • CAI’s TA Score: 4 bullish, 4 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CAI is a better buy in the short-term than VTGN.

Price Growth

CAI (@Biotechnology) experienced а -4.79% price change this week, while VTGN (@Biotechnology) price change was +10.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

CAI is expected to report earnings on Aug 18, 2026.

VTGN is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAI($4.97B) has a higher market cap than VTGN($25.9M). VTGN YTD gains are higher at: -4.759 vs. CAI (-35.841). CAI has higher annual earnings (EBITDA): 111M vs. VTGN (-69.2M). CAI has more cash in the bank: 823M vs. VTGN (61.8M). VTGN has less debt than CAI: VTGN (1.43M) vs CAI (431M). CAI has higher revenues than VTGN: CAI (907M) vs VTGN (789K).
CAIVTGNCAI / VTGN
Capitalization4.97B25.9M19,189%
EBITDA111M-69.2M-160%
Gain YTD-35.841-4.759753%
P/E RatioN/AN/A-
Revenue907M789K114,956%
Total Cash823M61.8M1,332%
Total Debt431M1.43M30,203%
FUNDAMENTALS RATINGS
CAI vs VTGN: Fundamental Ratings
CAI
VTGN
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5761
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
45n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAI's Valuation (1) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (15) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

CAI's Profit vs Risk Rating (100) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (100) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

VTGN's SMR Rating (99) in the Biotechnology industry is in the same range as CAI (100) in the Finance Or Rental Or Leasing industry. This means that VTGN’s stock grew similarly to CAI’s over the last 12 months.

CAI's Price Growth Rating (57) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (61) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

CAI's P/E Growth Rating (99) in the Finance Or Rental Or Leasing industry is in the same range as VTGN (100) in the Biotechnology industry. This means that CAI’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAIVTGN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
6%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
54%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
65%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
38%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
15%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CAI
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BERZ22.500.58
+2.65%
MicroSectors™ St FANG&Inn 3X Inv Ld ETNs
HDV27.030.04
+0.15%
iShares Core High Dividend ETF
PSTP36.68-0.05
-0.14%
Innovator Power Buffer Step-Up Stgy ETF
FFLG34.42-0.26
-0.74%
Fidelity Fundamental Large Cap Gr ETF
TSSD26.03-0.66
-2.48%
Truth Social American Security & DfnsETF

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
-6.28%
BMEA - CAI
38%
Loosely correlated
+5.08%
VTGN - CAI
29%
Poorly correlated
-5.94%
SNTI - CAI
26%
Poorly correlated
+4.91%
CRDF - CAI
22%
Poorly correlated
+7.02%
LIXT - CAI
20%
Poorly correlated
-1.97%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with KYTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-5.94%
KYTX - VTGN
45%
Loosely correlated
+2.91%
TRAW - VTGN
39%
Loosely correlated
+8.67%
REPL - VTGN
38%
Loosely correlated
+9.67%
SYRE - VTGN
38%
Loosely correlated
+13.54%
KROS - VTGN
37%
Loosely correlated
+3.19%
More